Rapid Evaluation of Vaccine Booster Effectiveness against SARS-CoV-2 Variants
Article
[키워드] 95% CI
appear
applied
approach
Blood
booster
booster vaccination
Booster vaccine
Cellulose
country
COVID
COVID-19 pandemic
decrease
evaluate
evaluated
heterogeneity
immune response
Immunity
immunological protection
increase in
indicated
individual
individual level
induce
median
MONITOR
NAb
Neutralization antibody
Neutralizing
Neutralizing antibodies
neutralizing antibody
omicron
Omicron variant
pandemic
POC
point of care
point-of-care
point-of-care test
population level
predominant
Protective
Rapid
regimen
reported
responses against
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 variants
shown
stick
switching
vaccination
variant
variants of concern
variants of SARS-CoV-2
virus neutralization test
VoC
VOCs
waning immunity
wild-type
[DOI] 10.1128/spectrum.02257-22 PMC 바로가기
[DOI] 10.1128/spectrum.02257-22 PMC 바로가기